• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.

作者信息

Flamaing Johan, Knockaert Daniël, Meijers Björn, Verhaegen Jan, Peetermans Willy E

机构信息

Department of Geriatric Medicine, University Hospitals Leuven, 3000 Leuven, Belgium.

出版信息

Aging Clin Exp Res. 2008 Feb;20(1):81-6. doi: 10.1007/BF03324752.

DOI:10.1007/BF03324752
PMID:18283233
Abstract

BACKGROUND AND AIMS

Community acquired lower respiratory tract infection (CALRTI) is the most common infection requiring hospitalization in the elderly. Sequential antibiotic therapy offers the potential for earlier functional rehabilitation, shorter length of hospital stay and lower costs. We studied the efficacy and safety of an empiric sequential antibiotic therapy with cefuroxime-cefuroxime axetil in elderly patients hospitalized with a CALRTI.

METHODS

A prospective, randomized, open-label, in-hospital study of cefuroxime IV 750 mg tid for 10 days (IV group) vs cefuroxime 750 mg IV tid for 3 days, followed by cefuroxime-axetil PO 500 mg bid for 7 days (sequence group), when clinical (symptoms improved and fever disappeared) and/or laboratory response [decrease in C-reactive protein (CRP)] occurred.

RESULTS

A total of 142 patients, 71 (mean age: 83.3 (+/-6 SD), M/F ratio: 1.1) in the IV group, and 71 (mean age: 81.5 (+/-7 SD), M/F ratio: 1.5) in the sequence group, were included in the study. Eighty-three (58.4%) presented with radiologically confirmed pneumonia (CAP) and 59 (41.6%) with non-pneumonic LRTI (NPLRTI) (p=ns between study groups). Treatment was considered effective in 84.5% (60/71) of patients in the IV group and 80.3% (57/71) in the sequence group (p=ns). Therapy failed in 15% (21/142) of the study population (p=ns between study groups) and, after day 3 of therapy, 8.45% (6/71) failed in both study groups. By the end of treatment, two patients had died in each study group, and total in-hospital mortality was 8.5% (12/142, p=ns between study groups). The length of hospital stay (LOS) did not differ between the two study groups.

CONCLUSIONS

When a favorable clinical or biochemical response occurs on day 3 of IV cefuroxime therapy, further therapy with oral cefuroxime-axetil is as effective and safe as a full course of cefuroxime IV in elderly patients hospitalized with CALRTI. However, LOS was not reduced after sequential antibiotic therapy in this population.

摘要

相似文献

1
Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.
Aging Clin Exp Res. 2008 Feb;20(1):81-6. doi: 10.1007/BF03324752.
2
Sequential therapy with cefuroxime followed by cefuroxime axetil in community-acquired pneumonia.头孢呋辛序贯治疗随后使用头孢呋辛酯治疗社区获得性肺炎。
Chest. 1997 Aug;112(2):406-15. doi: 10.1378/chest.112.2.406.
3
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.头孢呋辛酯:关于其在细菌感染治疗中应用的最新综述
Drugs. 2001;61(10):1455-500. doi: 10.2165/00003495-200161100-00008.
4
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.口服吉米沙星与静脉注射头孢曲松/口服头孢呋辛序贯治疗(联合或不联合大环内酯类药物)在社区获得性肺炎住院患者治疗中的应用:一项关于临床疗效和耐受性的随机、开放标签、多中心研究
Clin Ther. 2002 Nov;24(11):1915-36. doi: 10.1016/s0149-2918(02)80088-1.
5
Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.口服头孢呋辛酯与口服阿莫西林/克拉维酸治疗社区获得性肺炎的比较。
J Antimicrob Chemother. 1996 Mar;37(3):555-64. doi: 10.1093/jac/37.3.555.
6
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.克拉霉素、左氧氟沙星和头孢呋辛酯治疗成人慢性支气管炎急性细菌感染的疗效和耐受性的开放标签随机对照研究
Clin Ther. 2002 Sep;24(9):1414-25. doi: 10.1016/s0149-2918(02)80045-5.
7
A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
J Chemother. 1989 Jul;1(4 Suppl):768-9.
8
A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.口服头孢呋辛酯与口服阿莫西林治疗下呼吸道感染的比较。
J Antimicrob Chemother. 1985 Sep;16(3):373-8. doi: 10.1093/jac/16.3.373.
9
A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy.一项关于住院患者静脉注射抗生素治疗社区获得性肺炎的前瞻性随机研究。最佳治疗疗程。
Chest. 1996 Oct;110(4):965-71. doi: 10.1378/chest.110.4.965.
10
Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study.阿奇霉素短疗程序贯疗法与标准头孢呋辛序贯疗法治疗社区获得性肺炎的临床疗效及安全性:一项国际随机开放标签研究
J Chemother. 2005 Dec;17(6):636-42. doi: 10.1179/joc.2005.17.6.636.

引用本文的文献

1
An outpatient antibacterial stewardship intervention during the journey to JCI accreditation.在争取获得国际联合委员会(JCI)认证过程中的一项门诊抗菌药物管理干预措施。
BMC Pharmacol Toxicol. 2014 Feb 26;15:8. doi: 10.1186/2050-6511-15-8.